{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:02:39Z","timestamp":1791295359923,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.diagmicrobio.2016.08.026","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T20:15:59Z","timestamp":1473452159000},"page":"377-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7490-5369","authenticated-orcid":false,"given":"Didi","family":"Bang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Rytcher","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edita","family":"Vasiliauskien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-7598","authenticated-orcid":false,"given":"Erik Michael","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0005","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/AAC.05101-11","article-title":"Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan","volume":"55","author":"Ali","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0010","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/AAC.04058-14","article-title":"Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis","volume":"59","author":"Bernard","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00051-16","article-title":"Performance of the new V2.0 of the GenoType MTBDRsl test for the detection of resistance to second-line drugs in multidrug-resistant Mycobacterium tuberculosis complex strains","author":"Brossier","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0020","first-page":"170","article-title":"High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002","volume":"9","author":"Dewan","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0025","series-title":"ECDC ERLN-TB expert opinion on the use of the rapid molecular assays for the diagnosis of tuberculosis and detection of drug-resistance","article-title":"Stockholm; 2013","author":"ECDC","year":"2013"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0030","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/jac\/dks178","article-title":"The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region","volume":"67","author":"Gikalo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0035","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1128\/JCM.00081-09","article-title":"Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of mycobacterium tuberculosis strains and clinical specimens","volume":"47","author":"Hillemann","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0040","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1128\/JCM.00039-12","article-title":"Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study","volume":"50","author":"Ignatyeva","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0045","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/AAC.00851-09","article-title":"High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene","volume":"53","author":"Jugheli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0050","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/AAC.47.9.2971-2973.2003","article-title":"Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis","volume":"47","author":"Kr\u00fc\u00fcner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1128\/AAC.00920-10","article-title":"Molecular characterization of fluoroquinolone resistance in Mycobacterium tuberculosis: functional analysis of gyrA mutation at position 74","volume":"55","author":"Lau","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0060","doi-asserted-by":"crossref","first-page":"e39754","DOI":"10.1371\/journal.pone.0039754","article-title":"New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations","volume":"7","author":"Malik","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/AAC.49.2.571-577.2005","article-title":"Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis","volume":"49","author":"Maus","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0075","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1128\/AAC.49.8.3192-3197.2005","article-title":"Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis","volume":"49","author":"Maus","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0080","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1128\/AAC.00707-11","article-title":"DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis","volume":"55","author":"Pantel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0085","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.02191-12","article-title":"Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5\u00b4 untranslated region of whiB7","volume":"57","author":"Reeves","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/JCM.00750-06","article-title":"Detection of multidrug resistance in Mycobacterium tuberculosis","volume":"45","author":"Sekiguchi","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0095","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/JCM.01257-15","article-title":"Diagnostic performance of the new version (v2.0) of GenoType MTBDR sl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study","volume":"53","author":"Tagliani","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010705.pub2","article-title":"The diagnostic accuracy of the GenoType\u00aeMTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs","author":"Theron","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10096-008-0548-9","article-title":"Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates","volume":"27","author":"Vijdea","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0110","series-title":"WHO policy statement","article-title":"WHO molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0115","series-title":"WHO report","article-title":"WHO global tuberculosis","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0120","series-title":"Policy guidance on drug-susceptibility testing of second-line antituberculosis drugs","author":"World Health Organization (WHO)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0125","series-title":"Expert group meeting report","article-title":"The use of molecular line probe assay for the detection of resistance to second-line anti-tuberculosis drugs","author":"World Health Organization (WHO)","year":"2013"},{"key":"10.1016\/j.diagmicrobio.2016.08.026_bb0130","series-title":"WHO policy guidance","article-title":"The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs","author":"World Health Organization (WHO)","year":"2016"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316302668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316302668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T11:24:44Z","timestamp":1536405884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889316302668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0732889316302668"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.08.026","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}